Back to MW MARSHALL WACE, LLP
SNSE2 quarters
Position history for MWMARSHALL WACE, LLP's holdings in FAETH THERAPEUTICS INC
Yes. Marshall Wace holds 206,508 shares of SNSE (Faeth Therapeutics), worth $5.2M, as of its Q2 2026 13F filing. It increased the position from 65,730 shares in Q1 2026. Marshall Wace has held SNSE since Q1 2026, across 2 quarterly 13F filings.
Current Value
$5.2M
Current Shares
206,508
Total Value Change
+$3.1M
Total Shares Change
+140,778
Quarter-by-Quarter History
Other major holders of SNSE: Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, BALYASNY ASSET MANAGEMENT L.P., RA CAPITAL MANAGEMENT, L.P., FRANKLIN TEMPLETON INC